Brief: Napo Pharmaceuticals Announces Activation By FDA Of Investigational New Drug Application For Crofelemer
08/08/2023 15:02
Aug 8 (Reuters) - Jaguar Health Inc JAGX.O :
* NAPO PHARMACEUTICALS, A JAGUAR HEALTH COMPANY, ANNOUNCES
ACTIVATION BY FDA OF INVESTIGATIONAL NEW DRUG (IND) APPLICATION
FOR CROFELEMER FOR TREATMENT OF MICROVILLUS INCLUSION DISEASE
Source text for Eikon: ID:
Further company coverage: JAGX.O